These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31752231)

  • 21. Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies.
    Flashner BM; VanderLaan PA; Nurhussien L; Rice MB; Hallowell RW
    Respir Med; 2022 Jan; 191():106697. PubMed ID: 34864634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanics hands in patients with antisynthetase syndrome: 25 cases.
    Gusdorf L; Morruzzi C; Goetz J; Lipsker D; Sibilia J; Cribier B
    Ann Dermatol Venereol; 2019 Jan; 146(1):19-25. PubMed ID: 30595338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163.
    Ramos-Martínez E; Falfán-Valencia R; Pérez-Rubio G; Mejía M; Mejía-Hurtado JG; Buendía-Roldán I; González-Pérez MI; Mateos-Toledo HN; Rojas-Serrano J
    Immunol Lett; 2022 Aug; 248():56-61. PubMed ID: 35728747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 64-year-old woman with interstitial lung disease and positive antibodies against aminoacyl-transfer RNA synthetases in the absence of myositis: presentation of an anti-PL-12 positive antisynthetase syndrome.
    Ghysen K; Leys M
    Acta Clin Belg; 2018 Oct; 73(5):389-392. PubMed ID: 29173135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antisynthetase myopathy].
    Suzuki S
    Rinsho Shinkeigaku; 2020 Mar; 60(3):175-180. PubMed ID: 32101845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies.
    González-Pérez MI; Mejía-Hurtado JG; Pérez-Román DI; Buendía-Roldán I; Mejía M; Falfán-Valencia R; Mateos-Toledo HN; Rojas-Serrano J
    J Rheumatol; 2020 Mar; 47(3):415-423. PubMed ID: 31203227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single Nucleotide Polymorphism in the
    Ponce-Gallegos MA; González-Pérez MI; Mejía M; Nava-Quiroz KJ; Pérez-Rubio G; Buendía-Roldán I; Ramos-Martínez E; Rojas-Serrano J; Falfán-Valencia R
    Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33672430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).
    Rojas-Serrano J; Herrera-Bringas D; Mejía M; Rivero H; Mateos-Toledo H; Figueroa JE
    Clin Rheumatol; 2015 Sep; 34(9):1563-9. PubMed ID: 26219488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.
    Pinal-Fernandez I; Casal-Dominguez M; Huapaya JA; Albayda J; Paik JJ; Johnson C; Silhan L; Christopher-Stine L; Mammen AL; Danoff SK
    Rheumatology (Oxford); 2017 Jun; 56(6):999-1007. PubMed ID: 28339994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisynthetase Syndrome: The Classical Phenotype With a Twist.
    Betsikos A; Gazouni E; Bika S; Paschou E; Sabanis N
    Cureus; 2023 Jul; 15(7):e42360. PubMed ID: 37621814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and pathological findings of patients with interstitial lung disease associated with antisynthetase].
    Hara H; Inoue Y; Sato T
    Nihon Kokyuki Gakkai Zasshi; 2005 Nov; 43(11):652-63. PubMed ID: 16366363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
    Loganathan A; Zanframundo G; Yoshida A; Faghihi-Kashani S; Bauer Ventura I; Dourado E; Bozan F; Sambataro G; Yamano Y; Bae SS; Lim D; Ceribelli A; Isailovic N; Selmi C; Fertig N; Bravi E; Kaneko Y; Saraiva AP; Jovani V; Bachiller-Corral J; Cifrian J; Mera-Varela A; Moghadam-Kia S; Wolff V; Campagne J; Meyer A; Giannini M; Triantafyllias K; Knitza J; Gupta L; Molad Y; Iannone F; Cavazzana I; Piga M; De Luca G; Tansley S; Bozzalla-Cassione E; Bonella F; Corte TJ; Doyle TJ; Fiorentino D; Gonzalez-Gay MA; Hudson M; Kuwana M; Lundberg IE; Mammen AL; McHugh NJ; Miller FW; Montecucco C; Oddis CV; Rojas-Serrano J; Schmidt J; Scirè CA; Selva-O'Callaghan A; Werth VP; Alpini C; Bozzini S; Cavagna L; Aggarwal R;
    Clin Exp Rheumatol; 2024 Feb; 42(2):277-287. PubMed ID: 38488094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study.
    Jensen ML; Løkke A; Hilberg O; Hyldgaard C; Bendstrup E; Tran D
    Eur Clin Respir J; 2019; 6(1):1583516. PubMed ID: 30834073
    [No Abstract]   [Full Text] [Related]  

  • 36. Characteristics of chest high-resolution computed tomography in patients with anti-aminoacyl-tRNA synthetase antibody-positive interstitial lung disease.
    Mima M; Sato S; Shinya T; Naito N; Shoji T; Harada S; Suzue R; Murakami K; Koyama K; Nishioka Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Mar; 41(1):e2024005. PubMed ID: 38567566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic Profiles Among 72 Caucasian and Afro-Caribbean Patients with Antisynthetase Syndrome Involving Anti-PL7 or Anti-PL12 Autoantibodies.
    Abel A; Lazaro E; Ralazamahaleo M; Pierrisnard E; Suzon B; Bonnet F; Mercié P; Macey J; Agossou M; Viallard JF; Deligny C; Rivière E
    Eur J Intern Med; 2023 Sep; 115():104-113. PubMed ID: 37330316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases.
    Waseda Y; Johkoh T; Egashira R; Sumikawa H; Saeki K; Watanabe S; Matsunuma R; Takato H; Ichikawa Y; Hamaguchi Y; Shiraki A; Muro Y; Yasui M; Prosch H; Herold C; Kasahara K
    Eur J Radiol; 2016 Aug; 85(8):1421-6. PubMed ID: 27423682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antisynthetase syndrome and lung carcinoma: a fortuitous association?].
    Courties A; Lidove O; Maisonobe T; Rigolet A; Hermet A; Girard P; Ziza JM
    Rev Med Interne; 2014 Apr; 35(4):271-3. PubMed ID: 23726930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
    Lega JC; Cottin V; Fabien N; Thivolet-Béjui F; Cordier JF
    J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.